A Study to Evaluate the Efficacy and Safety of Abacavir+Lamivudine+Unboosted Atazanavir (ABC/3TC+ATV) in Patients With HIV Infections

Trial Profile

A Study to Evaluate the Efficacy and Safety of Abacavir+Lamivudine+Unboosted Atazanavir (ABC/3TC+ATV) in Patients With HIV Infections

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Atazanavir (Primary) ; Lamivudine/abacavir (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top